• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

What About a Deal With HP Inc. and DocuSign?

What boggles my mind is DocuSign sitting out there at $15 billion that could work well with HPQ - or Xerox - and their strong free cash flow.
By TIMOTHY COLLINS
Mar 05, 2020 | 01:57 PM EST
Stocks quotes in this article: HPQ, XRX, DOCU

I don't hate HP Inc. (HPQ) . I don't hate Xerox (XRX) . I do hate them together.

Hewlett Packard rejecting Xerox's latest $24 per share bid for the company is the correct move. I think of it this way, taking one dinosaur and putting it with another dinosaur didn't perpetuate life, evolution did. Neither of these companies appears to be doing much in the way of evolution on their own, so why would they succeed in such a plan together.

Take it one step further. Xerox is a $7.65 billion company focused on paying down a large amount of debt with its operating cash flow, then shipping the majority of the remaining cash flow out to investors either via dividend or buyback. That doesn't sound much like evolution, but more placating shareholders because the company doesn't know where to go.

So, what does it do? It tosses a Hail Mary $35 billion takeover offer for HPQ.

For a company with a debt to equity ratio of 1.0 and sitting at 20% the size of the takeover target, this seems like a goldfish trying to swallow the meals of a Great White.

Both companies produced solid results in their most recent quarter. Revenues basically in-line and EPS beat expectations by roughly 20%. The similarities were impressive. Both are producing free cash flow with similar yields as they payout free cash flow to shareholders. Xerox is also using operational cash flow to pay down a large amount of debt. Xerox did project upside for its FY2020 bottom line. HPQ did as well, but we already saw that upside in the Q1 recent results, so the next three quarters should net out in-line with expectations.

By tying up with Xerox, HPQ shareholders would get more of the same, but take on a partner that may have a consistent bottom line, but a falling top line. Additionally, Xerox's bid includes much more cash than the $1 billion they have on the books even after netting out HPQ's $4.5 billion in cash.

What boggles my mind is DocuSign (DOCU) sitting out there at $15 billion that could work well with either of these companies and their strong free cash flow. That number was closer to $11 billion when Xerox began this nonsense. They might have been able to snag DocuSign for $15 billion then. Instead, DocuSign continues to make its own small acquisitions as it moves into profitability while growing at 40%, growth Xerox could sorely use. With DocuSign's revenue approaching $1 billion, it would be enough to move the needle at Xerox, a company seeing its annual revenue dipping under $10 billion. In fact, it would move the revenue growth more than an acquisition of HPQ in terms of basis points.

HPQ would bring Xerox much more of the same. It would buy the company survival for the foreseeable future, but it would change the course of the asteroid heading towards these dinosaurs. HPQ will likely survive, but an investor will die from boredom while Xerox eventually gets snapped up for 1x or 2x earnings. Meanwhile, DocuSign will continue to pave the path of evolution. I don't think it's too late for either XRX or HPQ to make a move, but it will be soon.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Timothy Collins was Long DOCU.

TAGS: Investing | Stocks | Trading | Commercial & Professional Services | Consumer Products | Stock of the Day

More from Investing

Even Some Out of Fashion Names Are Now Back in Style

Jonathan Heller
Jan 27, 2023 12:30 PM EST

Sure, we're only one month in to 2023, but so far these stocks are starting the new year with a bang.

I'm Making Small Bets With These 2 Stocks

Bret Jensen
Jan 27, 2023 11:30 AM EST

While I remain cautious on the overall market, I continue to act upon the limited opportunities I'm finding in the current market.

Chevron Is Crushing It and for My Portfolio Too: Here's the Trade

Stephen Guilfoyle
Jan 27, 2023 10:51 AM EST

The only reason to exit the stock now is profit-taking.

Good Dividend Payers With Pretty Charts

Bruce Kamich
Jan 27, 2023 10:15 AM EST

You can have the best of both worlds -- at least when it comes to a select group of dividend stocks -- as we'll see in this first part of a two part series.

Adani Companies Plunge Under Hindenburg Attack, Hurting Secondary Sale Attempt

Alex Frew McMillan
Jan 27, 2023 9:30 AM EST

Retail investors may baulk now they are being offered Adani Enterprises shares at a range well above their current trading price.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • 03:06 PM EST BOB LANG

    LEAPS Webinar

    This week, I offered a free webinar session talkin...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login